Australia's most trusted source of pharma news
Thursday, 24 January 2019
Lost Your Access?
J&J in world's most admired
Only pharma in global all-stars list again.
New flu vax on fast track
But will likely miss out on 2019 season.
Allergan ANZ boss moves up
Gerry Muhle promoted to global medical aesthetics head.
Pipeline fuels Janssen growth
Fastest growing company on PBS has much more to come.
GSK rota vax lowers TD1
NIP listing sees big drop in diabetes diagnosis rates.
Epipen drought over at last
TGA declares shortage resolved almost a year after it began.
Pharma exec up for Aust of Year
NFP pharma hero nominated for 2019 Australian of the Year.
AZ hit by jobs scam
Second pharma targeted by fake recruiters for job seeker cash.
AZ staff make fast exit
Generic competitor may have triggered redundancies.
Novartis reps go virtual
Company bringing in AI assistance
Pharma worker charged
Attempted murder allegation follows multiple stabbings.
Monthly scripts anachronistic
Chronic meds should go much longer doc tells colleagues.
Will Keytruda finally be king?
End of Opdivo's reign one of our 2019 PBS predictions.
De Somer wants govt to commit
As the election nears, MA boss calls for clarity on PBS future.
New Roche blood drug arrives
First-in-class scores first priority review tag for 2019.
What next for Novo Nordisk?
Declining PBS income first challenge for incoming MD.
Claytons election campaign
Leaders hit the hustings with baby-kissing already underway.
New form of Bayer's Xarelto
PBS listing awaits with competition already registered.
Novartis' sickle cell breakthrough
Plus new approvals for Pfizer, BMS.
Events & Conferences
© 2003 - 2019 Lush Media
Pharma in Focus
Jolly Good Design